Month: July 2023

Rackspace Technology Partners with C2C Global, the Largest Online Google Cloud Customer Community

Written by Customer Service on July 5, 2023. Posted in Public Companies.

Rackspace Technology helps organizations of all sizes plan, architect, and operate projects at scale by leveraging its Google Cloud-certified experts and the latest technologies SAN ANTONIO, July 05, 2023 (GLOBE NEWSWIRE) — Rackspace Technology® (NASDAQ: RXT)— a leading end-to-end, multicloud technology solutions company, today announced that it has entered into a new partnership with C2C Global, the largest worldwide community of Google Cloud users. As Google Cloud’s first managed services partner, Rackspace Technology helps organizations of all sizes plan, architect, and operate projects at scale by leveraging its Google Cloud-certified experts. Rackspace Technology is constantly investing and creating new partnerships to strengthen the relationship with Google Cloud to deliver unparalleled services and solutions. Just recently,...

Stellantis Reveals STLA Medium Platform Designed to Electrify the Heart of the Global Market with Future-Proof Customer Innovations

Written by Customer Service on July 5, 2023. Posted in Public Companies.

Stellantis Reveals STLA Medium Platform Designed to Electrify the Heart of the Global Market with Future-Proof Customer InnovationsSTLA Medium is designed to meet customer expectations on what matters most to them: Best-in-class range of more than 700 km (435 miles), charging time, performance, efficiency, affordability, driving pleasure STLA Medium is the first of four global BEV platforms to be launched less than two years after EV Day presentation in July 2021 Flexibility of STLA Medium enables one platform to host several brands’ passenger cars, crossovers and SUVs in C and D segments – the heart of the global vehicle market STLA Medium will be installed in several plants to support bold electrification ambition, starting with EuropeAMSTERDAM, July 5, 2023 – Stellantis N.V. today unveiled STLA Medium, a global BEV-by-design platform...

Sensor Pills of the Future: Ingestible Sensor Market Set to Soar Past USD 1800 million by 2030 | Skyquest Technology

Written by Customer Service on July 5, 2023. Posted in Mergers And Acquisitions.

Explore the Ingestible Sensor market size, share, and growth analysis from 2023 to 2030. Dive into the components, including Sensors, Data Recorders, and Software Types. Experience the diverse applications in Verticals like Medical and Sports & Fitness. Discover the fascinating capabilities measuring Temperature, Pressure, pH, and even Image Sensors hold. Westford, USA, July 05, 2023 (GLOBE NEWSWIRE) — The global Ingestible Sensor market size is expected to reach USD 1800 million by 2030 and exhibit a CAGR of 10.9% in the forecast period (2023−2030), according to Skyquest’s latest research report. The increasing adoption of digital health technologies and wearable devices, rising prevalence of chronic diseases and the need for remote patient monitoring, advancements in sensor technology and miniaturization, growing demand...

LiveOne Surges with Record 75K New Members in June

Written by Customer Service on July 5, 2023. Posted in Earnings Releases And Operating Results.

Quarterly Members Expanded by 194K, a 59% Increase from Prior Year 6 Month Members Shot up by 371K, a 64% Increase from Prior Year at Average ARPU over $3 Finished June 30th at 3.2 Million Members, up 33% from Prior Year Tesla Members Leaped 60%+ from Prior Fiscal Year Expects $26.5 – 27.5 Million in Revenues for June Quarter LOS ANGELES, CA, July 05, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – LiveOne (Nasdaq: LVO), an award-winning, creator-first music, entertainment, and technology platform, announced today that it has broken multiple membership records. Contributing to this surge is Tesla, LiveOne’s largest customer, who achieved a record-breaking delivery of over 466K cars through June and raised their yearly guidance to 2.4 million cars. LiveOne’s CEO and Chairman, Robert Ellin, commented, “We’re...

The Allergy Antidote: Allergy Immunotherapy Market Set to Soar Past USD 4.9 Billion by 2030 | Skyquest Technology

Written by Customer Service on July 5, 2023. Posted in Mergers And Acquisitions.

Explore allergy immunotherapy market size, share, and growth analysis from 2023 to 2030. Witness the power of Subcutaneous Immunotherapy, Sublingual Immunotherapy, and Oral Allergy Immunotherapy, targeting Allergic Rhinitis, Asthma, Food Allergy, and Drug Allergy. Discover the diverse distribution channels including Hospital Pharmacies, Retail Pharmacies, Drug Stores, and Online Pharmacies. Westford USA, July 05, 2023 (GLOBE NEWSWIRE) — The global Allergy Immunotherapy market size is expected to reach USD 4.9 billion by 2030 and exhibit a CAGR of 10.8% in the forecast period (2023−2030), according to Skyquest’s latest research report. The growing prevalence of allergies and allergic diseases, increasing awareness about the benefits of allergy immunotherapy, advancements in allergy diagnostics and treatment options, rising...

CGrowth Capital Inc. Discovers Significant High-Grade Lithium Deposits

Written by Customer Service on July 5, 2023. Posted in Public Companies.

NEW YORK, NY, July 05, 2023 (GLOBE NEWSWIRE) — via NewMediaWire — CGrowth Capital Inc. (OTC: CGRA) is pleased to announce the publication of a high-level preliminary report of its exploration efforts in the company’s recently acquired lithium tenements in the Hombolo region of Tanzania. This preliminary report reveals promising indications of significant lithium mineralization along with key geological sequences and notable results obtained from rock chip sampling, confirming the presence of valuable lithium resources. The report offers a concise overview of the initial exploration conducted at the Mohanga Lithium tenement situated in Makulu Village, Bahi and Dodoma Urban districts of the Dodoma region in Central Tanzania. Additionally, it presents a comprehensive account of the mining licenses secured, encompassing 17 prospecting...

Half-year statement on Nexans liquidity contract – January 1st to June 30th, 2023

Written by Customer Service on July 5, 2023. Posted in Public Companies.

Half-year liquidity contract statement for Nexans _PRESS RELEASE_ Paris, July 5th, 2023 – Pursuant to the liquidity contract granted by NEXANS to NATIXIS ODDO BHF, the following assets appeared on the dedicated liquidity account as of June 30th, 2023:48,255 shares EUR 2,845,423.47 in cash Number of purchase transactions executed over the semester: 3,294 Number of sales transactions executed over the semester: 3,272 Volume traded over the semester for purchase: 561,706 shares for EUR 47,458,552.85 Volume traded over the semester for sales: 541,402 shares for EUR 45,982,449.30As a reminder, the following assets appeared on the last half-year report as of December 31st 2022, on the dedicated liquidity account:27,951 shares EUR 4,321,523.32 in cash Number of purchase transactions executed over the semester: 4,080 Number of sales transactions...

Lung Cancer Therapeutics Market to Worth USD 66407.15 Million by 2030 | Skyquest Technology

Written by Customer Service on July 5, 2023. Posted in Mergers And Acquisitions.

The lung cancer therapeutics market is segmented based on cancer type, molecule type, treatment type and end user. Based on cancer type, the market is segmented into non-small cell lung cancer, metastatic lung cancer, pulmonary neuroendocrine tumours, mediastinal tumours, mesothelioma, and chest wall tumours. The market is segmented into small molecules and biologics based on molecule type. According to treatment type, the market is further sub-segmented into chemotherapy, radiation therapy, targeted therapy, and immunotherapy. Based on end users, the market is further sub-segmented into hospitals, homecare, speciality clinics and others – Industry Forecast 2023-2030 Westford USA, July 05, 2023 (GLOBE NEWSWIRE) — According to SkyQuest, the global lung cancer therapeutics market is projected to experience a substantial growth...

Initial Data from Allarity’s Phase 2 Trial of IXEMPRA® Indicate Potential for Improved Clinical Benefit in DRP®-Selected Metastatic Breast Cancer Patients

Written by Customer Service on July 5, 2023. Posted in Public Companies.

Boston, MA (July 5, 2023) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (Nasdaq: ALLR), a clinical-stage pharmaceutical company developing novel oncology therapeutics together with drug-specific DRP® companion diagnostics for personalized cancer care, today announced initial results from its European Phase 2 clinical trial evaluating the efficacy of IXEMPRA® in metastatic breast cancer (mBC) patients selected with the DRP®-IXEMPRA® companion diagnostic (CDx) candidate. Researchers prescreened mBC patients using Allarity’s DRP®-IXEMPRA® CDx, a complex transcriptomic signature comprising multiple mRNA biomarkers of drug response/resistance. Patients were assigned a DRP®-score, and those with scores above 67% were selected for treatment with IXEMPRA®. Of the 36 patients screened with the DRP®-IXEMPRA® CDx, investigators identified...

Magna Announces Date for Q2 2023 Results Call

Written by Customer Service on July 5, 2023. Posted in Public Companies.

AURORA, Ontario, July 05, 2023 (GLOBE NEWSWIRE) — Magna International Inc. (TSX:MG) (NYSE:MGA) MAGNA ANNOUNCES DATE FOR Q2 2023 RESULTS CALLFRIDAY – AUGUST 4, 20238:00 AM ET DIAL IN NUMBERSToll-Free: 1-800-899-2086International: 1-416-641-6701Webcast: www.magna.com Slide presentation will be available on our website prior to the call REBROADCAST INFORMATIONReplay available 2 hours after the call until August 11, 2023Toll-Free: 1-800-558-5253International: 1-416-626-4100Reservation No.: 22027512INVESTOR CONTACTLouis Tonelli, Vice-President, Investor Relations louis.tonelli@magna.com 905-726-7035 TELECONFERENCE CONTACTNancy Hansford, Executive Assistant, Investor Relations nancy.hansford@magna.com 905-726-7108

Month: July 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals